SRT1720, a potent activator of SIRT1, promotes renal fibrosis via increased phosphorylation of epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor β (PDGFRβ). This evidence concerns the gene EGFR and renal fibrosis.